Marrone Bio Innovations Inflation Of R Evenues By

Marrone Bio Innovations Inflation of RevenuesBy nameMarrone Bio InnovationsInc. (MBII) is the latest big company to have been found guilty of committing accounting frauds, on February 17, 2016. Marrone, a leading company in bio based products for pest management and plant health admitted to inflating financial results to meet projections it would double revenues in its first year as a public company (Sec.gov). Also charged, was Hector Absi, Marrone’s former chief operating officer (COO), for artificially inflating the company’s reported revenues by millions of dollars. The company has agreed to pay a $1.75 million penalty to settle the SEC’s charges.The company in its first financial year as a public traded company felt that the revenues generated were not enough to impress investors. Therefore, according to SEC complaints resulted in misguiding the investors into thinking that Marrone was a first growing company. First, the COO offered distributors “inventory protection,” a concession that allowed distributors to return unsold product to appear that the revenues were high (Sec.gov). Second, he directed his subordinates to obtain false sales and shipping documents and intentionally ship the wrong product to book sales. Third, the COO manipulated the company’s expense reporting system to